LIMNW vs WTW
Liminatus Pharma, Inc. Warrants (LIMNW) versus Willis Towers Watson PLC (WTW) — a side-by-side from cached financials, not a winner call.
Liminatus Pharma, Inc. Warrants (LIMNW) is a biotechnology company listed on US.
Willis Towers Watson PLC (WTW) is a insurance brokers company listed on NASDAQ.
LIMNW does not have a complete income-statement cache yet.
Latest reported WTW revenue for 2026-06-30 was $4.88B. Net income was $526.0M. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
LIMNW currently screens at market cap $0. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
Not investment advice. Open the LIMNW and WTW stock pages for the full models.
Not investment advice.